https://www.selleckchem.com/pr....oducts/Vorinostat-sa
Previous evidence suggests that acute kidney injury (AKI) is common in patients with COVID-19 and associated with adverse outcomes. Moreover, the incidence and mortality of AKI in Asia are ambiguous. Evaluating the risk factors and risk of death from AKI in -COVID-19 patients in Asia. We conducted a meta-analysis of clinical observational studies of -COVID-19 patients in Asia. Outcome measures included AKI in COVID-19 patients, overall mortality in COVID-19 patients, and mortality assessment in patients with AKI. The random-effe
Me gusta
Comentario
Compartir
